Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XLV vs. IYH: which is better?

Bottom line

XLV vs IYH: the short answer

XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and IYH (iShares U.S. Healthcare ETF) have nearly the same top holdings — their top 25 positions are about 90% the same by weight.

XLV is cheaper at 0.08% vs 0.37% — a difference of $29 a year per $10,000 invested.

Over five years, XLV returned +8.1% a year vs +7.0% for IYH.

Updated Nov 19, 2026

XLV vs IYH side by side

XLVIYH
TypeETFETF
Fund familySPDR (State Street)iShares
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.08%0.37%
Annual cost per $10k$8$37
10-yr cost on $10k (prospectus)$103$468
Max front loadNoneNone
12b-1 fee0.02%0%
1-yr return+14.5%+13.1%
5-yr return (annualized)+8.1%+7.0%
10-yr return (annualized)+9.8%+9.4%
Best quarter+14.5%+15.3%
Worst quarter−12.7%−12.7%
Net assets (fund)$40.6B$3.6B
Number of holdings65103
Portfolio turnover2%3%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearXLVIYHDifference
2025+14.5%+13.1%+1.4%
2024+2.5%+3.1%−0.6%
2023+2.0%+2.1%−0.1%
2022−2.1%−4.4%+2.3%
2021+25.9%+23.4%+2.5%
2020+13.3%+15.5%−2.2%
2019+20.7%+20.8%−0.2%
2018+6.3%+5.9%+0.4%
2017+21.7%+22.3%−0.6%
2016−2.8%−2.8%−0.0%

Source: Fund prospectus bar charts

Holdings overlap

20 of XLV's top 25 holdings also appear in IYH's top 25.

Shared top holdings
HoldingXLVIYH
Eli Lilly & Co16.51%15.11%
Johnson & Johnson10.64%10.17%
AbbVie Inc7.74%7.32%
UnitedHealth Group Inc6.57%6.16%
Merck & Co Inc5.52%5.31%
Amgen Inc3.40%3.42%
Thermo Fisher Scientific Inc3.24%3.52%
Abbott Laboratories2.75%3.02%
Gilead Sciences Inc2.73%2.66%
Intuitive Surgical Inc2.45%2.05%
Pfizer Inc2.39%2.35%
Vertex Pharmaceuticals Inc2.19%2.00%
Danaher Corp2.09%2.03%
Bristol-Myers Squibb Co2.05%2.20%
Stryker Corp1.89%1.86%

Source: SEC Form N-PORT

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

IYH top 10

  1. Eli Lilly And Company — 15.11%
  2. Johnson & Johnson — 10.17%
  3. Abbvie Inc. — 7.32%
  4. Unitedhealth Group Incorporated — 6.16%
  5. Merck & Co., Inc. — 5.31%
  6. Thermo Fisher Scientific Incorporated — 3.52%
  7. Amgen Inc. — 3.42%
  8. Abbott Laboratories — 3.02%
  9. Gilead Sciences, Inc. — 2.66%
  10. Pfizer Inc. — 2.35%

FAQ

What is the difference between XLV and IYH?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and IYH (iShares U.S. Healthcare ETF) have nearly the same top holdings — their top 25 positions are about 90% the same by weight. XLV is cheaper at 0.08% vs 0.37% — a difference of $29 a year per $10,000 invested.
Which is cheaper, XLV or IYH?
XLV has the lower expense ratio (0.08%).
Should I own both XLV and IYH?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.